ConvaTec
Sector/industry
Wound care and therapeutic products
ConvaTec is a leading developer and marketer of innovative
medical technologies. With four key business divisions, ostomy
care, wound therapeutics, continence and critical care and infusion
devices, ConvaTec products support health care professionals from
the hospital to the community health setting. The company has
operations in over 90 countries serving consumers and health care
professionals on six continents.
Nordic Capital Fund´s VI and VII, together with Avista Capital
partners acquired Convatec from Bristol Myers Squibb in August
2008.
After the acquisition by Nordic Capital, ConvaTec has integrated
Unomedical, a leading manufacturer of single-use medical devices
based in Copenhagen and a Nordic Capital portfolio company since
2003.
Management:
- David I. Johnson, CEO
- Ed Borkowski, CFO
Board of Directors:
- Toni Weitzberg, Chairman
- David Burgstahler
- Thompson Dean
- David I. Johnson
- Kristoffer Melinder
Key Information:
Revenues 2010*:
EUR 1140 million
Employees:
7750
Ownership:
Nordic Capital Fund VI and Nordic Capital Fund VII, controlling shareholding
Date of investment:
2008
* 2010 sales for companies still in portfolio; sales at exit for divested companies
